Keith D. Terry
No más puestos en curso
Historial de carrera de Keith D. Terry
Antiguos cargos conocidos de Keith D. Terry.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
PathoGenesis Corp
 PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Corporate Officer/Principal | - | - |
OcuSub, Inc.
 OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Fundador | 01/03/2002 | - |
| Corporate Officer/Principal | 04/11/2009 | - |
Formación de Keith D. Terry.
| University of Wisconsin | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 5 |
Operativa
| Corporate Officer/Principal | 2 |
| Founder | 1 |
| Undergraduate Degree | 1 |
Sectorial
| Health Technology | 3 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
OcuSub, Inc.
OcuSub, Inc. BiotechnologyHealth Technology OcuSub, Inc. engages biotechnology services. It specializes in eye disorder treatment. The company was founded by Mina Patel Sooch, Alan R. Meyer, and William H. Pitlick in 2018 and is headquartered in Farmington Hills, MI. | Health Technology |
PathoGenesis Corp
PathoGenesis Corp BiotechnologyHealth Technology Part of Novartis AG, PathoGenesis Corp is a company that develops and markets innovative treatments for chronic infectious diseases. The company is based in Seattle, WA. The company was founded by Isaac Blech. PathoGenesis was acquired by Chiron Corp. on September 19, 2000 for $639.75 million. | Health Technology |
- Bolsa de valores
- Insiders
- Keith D. Terry
- Experiencia
